Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications

Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications

US Patent 8859240 · Granted Oct 14, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use f2024
Lassa vaccine2024
Recombinant measles virus expressing zika virus prM and E proteins2024
Lentiviral vector-based Japanese encephalitis immunogenic composition2023
Lentiviral vector-based Japanese encephalitis immunogenic composition2023
Recombinant measles vaccine expressing hTERT2022
Live recombinant measles-M2 virus—its use in eliciting immunity against influenz2021
Dengue virus chimeric polyepitope composed of fragments of non-structural protei2021
Compositions and methods comprising measles virus defective interfering particle2021
Compositions and methods comprising measles virus defective interfering particle2021
Use of a genetically modified infectious measles virus with enhanced pro-apoptot2021
Use of a genetically modified infectious measles virus with enhanced pro-apoptot2021